Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
about
Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.Effects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapyProspective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancer.Current vaccine updates for lung cancer.γδ T-cell immunotherapy for lung cancer.Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.γδ T cell therapy for the treatment of non-small cell lung cancer.Therapeutic vaccination for non-small-cell lung cancer: a meta-analysis.Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.Sipuleucel-T and immunotherapy in the treatment of prostate cancer.
P2860
Q31050197-A7A79592-8567-4116-AB67-4EEEBC6A4871Q34023502-BBDE750F-658D-4346-99E3-F121AC36B0A4Q34277777-9DA3880F-36E0-49A8-9821-EE6774CC845FQ34918975-D68BD11E-BDAD-484E-A30B-ED2DBB3E3548Q36821194-96140169-02F8-405B-8163-574910FFA4D8Q37706593-99427DB7-E6E8-466F-B536-E69ED9FD7DCBQ37870836-0C97DB6F-56DD-4711-A8CA-C8F069CA2C58Q38051222-47B1670A-5D3F-4CD0-B226-B3257980BF5FQ38390100-88E4FE9A-DC67-4748-BFEE-627F098F8722Q39227338-FA9A03A1-E5B2-4701-A18F-FB9AF5BDE943Q40200213-9D6C4E98-050C-4C48-9E5A-81B1D525BA0EQ40224948-F6D37EC0-DD31-4C04-B246-447A11D0F624Q45246341-7E4193A9-29E6-474A-8751-612F45A8A5FBQ53062915-C55F1D23-239B-4C8A-8C47-58BA1E95FB06
P2860
Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Active specific immunotherapy ...... of non-small cell lung cancer.
@en
Active specific immunotherapy ...... of non-small cell lung cancer.
@nl
type
label
Active specific immunotherapy ...... of non-small cell lung cancer.
@en
Active specific immunotherapy ...... of non-small cell lung cancer.
@nl
prefLabel
Active specific immunotherapy ...... of non-small cell lung cancer.
@en
Active specific immunotherapy ...... of non-small cell lung cancer.
@nl
P1433
P1476
Active specific immunotherapy ...... of non-small cell lung cancer
@en
P2093
Hiromi Wada
Kazuhiro Kakimi
P356
10.1016/J.LUNGCAN.2008.10.018
P50
P577
2008-12-04T00:00:00Z